Tema ETFs LLC
Mutual FundPosition in BBOT — BridgeBio Oncology Therapeutics, Inc.
CIK 2056807
New York, NY
Position in BBOT
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$735,439
New position
Shares Held
82,172
first reported quarter
Ownership
0.103%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#40
of 67 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tema ETFs LLC holds $98,647,535 across 48 Biotechnology names. BBOT ranks #29 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
98,178 | $9,547,810 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
112,273 | $8,337,392 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
176,667 | $6,799,912 | |
| 4 | IMNM |
Immunome Inc.
|
275,896 | $6,033,845 | |
| 5 | NUVL |
Nuvalent, Inc.
|
53,415 | $5,472,366 | |
| 6 | CELC |
Celcuity Inc.
|
45,725 | $5,219,051 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,640 | $4,304,645 | |
| 8 | CGON |
CG Oncology, Inc.
|
63,163 | $4,274,871 |
All Filings in BBOT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $735,439 | 82,172 | Shares | Sole | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||